Bibliography
- Wilson JT : An update on the therapeutic orphan.Pediatrics104, 585–590(1999).
- Benjamin DK Jr, Smith PB, Murphy MD et al.: Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA296, 1266–1273(2006).
- Specific Requirements on Content and Format of Labeling for Human Prescription Drugs: Revision of “Pediatric Use” subsection of Labeling. 59 Federal Register 64242 (1994).
- Food and Drug Administration Modernization Act of 1997, Pub. L No. 105–115.
- Best Pharmaceuticals for Children Act of 2002, Pub. L No. 107–109.
- Boots I , SukhaiRN, KleinRHet al.: Stimulation programs for pediatric drug research – do children really benefit?Eur. J. Pediatr.166(8), 849–855(2007).
- Li JS , EisensteinEL, GrabowskiHGet al.: Economic return of clinical trials performed under pediatric exclusivity.JAMA297, 480–488(2007).
- Roberts R , RodriguezW, MurphyD, CrescenziT: Pediatric drug labeling, improving the safety and efficacy of pediatric therapies.JAMA290, 905–911(2003).
- Faucher JF , BinderR, MissinousMAet al.: Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin. Infect. Dis.35, 1147–1154(2002).
- Camus D , DjossouF, SchilthuisHJet al.: Atovaquone-proguanil in nonimmune pediatric travelers: results of an international, randomized, open-label study.Clinical Infectious Diseases38, 1716–1723(2004).
- Sabchaeron A , AttanathP, PhanuaksookPet al.: Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg.92, 201–206(1998).
- Anabwani G , CanfieldCJ, HutchinsonD: Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute plasmodium falciparum malaria in children.Pediatr. Infect. Disease J.18, 456–461(1999).
- Lell B , LucknerD, NdjaveM, ScottT, KremsnerPG: Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.Lancet351, 709–713(1998).
- Select Panel for the Promotion of Child Health to the United States Congress and the Secretary of Health and Human Services. Better health for our children: 4 volumes. Public Health Service Washington, DC, USA (1981).
Website
- Office of Pediatric Therapeutics www.fda.gov/oc/opt/default.htm